Karayan-Tapon L - Search Results

1

Association between clinicopathological characteristics and RAS mutation in colorectal cancer.

Rimbert J, Tachon G, Junca A, Villalva C, Karayan-Tapon L, Tougeron D. Rimbert J, et al. Mod Pathol. 2018 Mar;31(3):517-526. doi: 10.1038/modpathol.2017.119. Epub 2017 Oct 20. Mod Pathol. 2018. PMID: 29052598 Free article.

2

STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?

Villalva C, Martin-Lannerée S, Cortes U, Dkhissi F, Wager M, Le Corf A, Tourani JM, Dusanter-Fourt I, Turhan AG, Karayan-Tapon L. Villalva C, et al. Int J Cancer. 2011 Feb 15;128(4):826-38. doi: 10.1002/ijc.25416. Int J Cancer. 2011. PMID: 20473906 Free article.

3

O6-Methylguanine-methyltransferase (MGMT) promoter methylation status in glioma stem-like cells is correlated to temozolomide sensitivity under differentiation-promoting conditions.

Villalva C, Cortes U, Wager M, Tourani JM, Rivet P, Marquant C, Martin S, Turhan AG, Karayan-Tapon L. Villalva C, et al. Int J Mol Sci. 2012;13(6):6983-6994. doi: 10.3390/ijms13066983. Epub 2012 Jun 7. Int J Mol Sci. 2012. PMID: 22837675 Free PMC article.

4

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer.

Tougeron D, Lecomte T, Pagès JC, Villalva C, Collin C, Ferru A, Tourani JM, Silvain C, Levillain P, Karayan-Tapon L. Tougeron D, et al. Ann Oncol. 2013 May;24(5):1267-73. doi: 10.1093/annonc/mds620. Epub 2013 Jan 4. Ann Oncol. 2013. PMID: 23293113 Free article.

5

Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.

Tougeron D, Cortes U, Ferru A, Villalva C, Silvain C, Tourani JM, Levillain P, Karayan-Tapon L. Tougeron D, et al. Cancer Chemother Pharmacol. 2013 Aug;72(2):397-403. doi: 10.1007/s00280-013-2211-0. Epub 2013 Jun 14. Cancer Chemother Pharmacol. 2013. PMID: 23765179

6

EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients.

Villalva C, Duranton-Tanneur V, Guilloteau K, Burel-Vandenbos F, Wager M, Doyen J, Levillain PM, Fontaine D, Blons H, Pedeutour F, Karayan-Tapon L. Villalva C, et al. Cancer Med. 2013 Jun;2(3):296-304. doi: 10.1002/cam4.82. Epub 2013 Apr 23. Cancer Med. 2013. PMID: 23930206 Free PMC article.

7

A mesenchymal glioma stem cell profile is related to clinical outcome.

Balbous A, Cortes U, Guilloteau K, Villalva C, Flamant S, Gaillard A, Milin S, Wager M, Sorel N, Guilhot J, Bennaceur-Griscelli A, Turhan A, Chomel JC, Karayan-Tapon L. Balbous A, et al. Oncogenesis. 2014 Mar 17;3(3):e91. doi: 10.1038/oncsis.2014.5. Oncogenesis. 2014. PMID: 24637491 Free PMC article.

8

Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre study.

Tougeron D, Sickersen G, Mouillet G, Zaanan A, Trouilloud I, Coriat R, Aparicio T, Des Guetz G, Lecaille C, Artru P, Cauchin E, Sefrioui D, Boussaha T, Ferru A, Matysiak-Budnik T, Silvain C, Karayan-Tapon L, Pagès JC, Vernerey D, Bonnetain F, Michel P, Taïeb J, Lecomte T; Association des Gastro-Entérologues Oncologues (AGEO). Tougeron D, et al. Eur J Cancer. 2015 May;51(8):925-34. doi: 10.1016/j.ejca.2015.03.011. Epub 2015 Apr 8. Eur J Cancer. 2015. PMID: 25864037

9

Development of pyrosequencing methods for the rapid detection of RAS mutations in clinical samples.

Cortes U, Guilloteau K, Rouvreau M, Archaimbault C, Villalva C, Karayan-Tapon L. Cortes U, et al. Exp Mol Pathol. 2015 Oct;99(2):207-11. doi: 10.1016/j.yexmp.2015.07.003. Epub 2015 Jul 8. Exp Mol Pathol. 2015. PMID: 26163758

10

Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.

Tougeron D, Mouillet G, Trouilloud I, Lecomte T, Coriat R, Aparicio T, Des Guetz G, Lécaille C, Artru P, Sickersen G, Cauchin E, Sefrioui D, Boussaha T, Ferru A, Matysiak-Budnik T, Silvain C, Karayan-Tapon L, Pagès JC, Vernerey D, Bonnetain F, Michel P, Taïeb J, Zaanan A. Tougeron D, et al. J Natl Cancer Inst. 2016 Feb 1;108(7). doi: 10.1093/jnci/djv438. Print 2016 Jul. J Natl Cancer Inst. 2016. PMID: 26839356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page